ArticleTranslational oncology2025

TTC7A-ALK, a novel ALK fusion variant identified in a patient with metastatic lung adenocarcinoma, exhibits excellent response to crizotinib.

Meijin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.